01952.HK
Everest Medicines Limited
HKSE · Healthcare · Biotechnology · CN
HKD 27.02
−9.27%Margins
Gross margin
69.8%
EBITDA margin
2.7%
EBIT margin
-5.3%
Net margin
-2.2%
FCF margin
-11.7%
-1.0%
Return on equity
-0.6%
Return on assets
-1.8%
Return on invested capital
0.29x
Asset turnover
-HKD 216.4M
Cash from operations
HKD 7.13
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026